Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
1.690
-0.410 (-19.52%)
Nov 16, 2026, 3:37 PM EST - Market open
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $10.56 million as of November 16, 2026. It is the 39,650th most valuable company in the world and the 5,387th biggest in the United States. Its market cap has decreased by 74.23% in one year.
Market Cap
10.56M
Enterprise Value
-8.63M
1-Year Change
-74.23%
Global Rank
Country Rank
#5,387 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $10.56M, a decrease of -98.09%. That is a compound annual growth rate of -47.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 10.56M | -81.59% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 14.27M |
| Quantum BioPharma | 14.11M |
| Kyntra Bio | 13.93M |
| Neuphoria Therapeutics | 13.80M |
| Passage Bio | 13.68M |
| Pluri | 12.96M |
| Daré Bioscience | 12.93M |
| BioCardia | 12.58M |